Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Elevated Health vs Omada Health

Elevated Health
Graded #285

Higher grade

vs+6.199999999999996
Omada Health
Graded #436

Lower grade

The verdict

Elevated Health takes it — 61.8/100 to 55.6/100.

Elevated Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Elevated Health offers compounded semaglutide ($176/mo) and compounded tirzepatide ($238/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOmada Health +8
37
45
Dose & formulationElevated Health +48
88
40
Clinical oversightOmada Health +3
74
77
Labs & monitoringOmada Health +9
52
61
FulfillmentEven
62
62
Contract termsElevated Health +6
61
55
Elevated Health · left barOmada Health · right bar

The numbers

MetricElevated HealthOmada Health
WeighScore61.8/10055.6/100
GradeCC
Scorecard rank#285#436
Semaglutide$296/mo (compounded)Not disclosed
Tirzepatide$359/mo (compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Elevated Health

Graded #285 · C

Strengths

  • $100 off first month
  • Oral semaglutide option
  • Competitive pricing — compounded semaglutide from $187/mo (12-month plan), tirzepatide from $235/mo

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity or address disclosed
  • State availability not disclosed
  • Shopify storefront — few clinical infrastructure signals
Omada Health

Graded #436 · C

Strengths

  • Added GLP-1 prescribing and medication management in late 2025
  • Clinicians trained in obesity care, available in all 50 states
  • Behavioral support wrapped before, during and after treatment
  • GLP-1 Flex Care adds a cash-pay medication pathway in 2026
  • Publicly traded, evidence-based virtual care platform

Where it loses points

  • Core program distributed via employers and health plans, limited cash-pay
  • GLP-1 prescribing is a recent addition still scaling
  • GLP-1 Flex Care only rolling out to employers later in 2026
  • No transparent published price for the core member program

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard